Neelkanth (512565)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹41.39 |
| Market Cap | ₹18.6 Cr |
| P/E Ratio | 37.41 |
| ROCE | 0.5% |
| ROE | 6.87% |
| Dividend Yield | 0% |
| Profit Growth | 920% |
| Debt/Equity | — |
| Sales Growth | 114.06% |
| 52-Week Range | ₹27.16 — ₹57 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹21.62 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹41.39, this is a ₹19 Cr micro-cap trading business selling at 37 times earnings and 1.91 times book. Book value is ₹21.62, so I am paying a substantial premium for a company earning only 6.87% on equity and 0.50% on capital. Those returns are far below what I expect from a durable business. The 114% sales growth and 920% profit growth look spectacular, but the latest quarter tells a sobering story: sales of ₹1 Cr and net profit of ₹0 Cr. That kind of volatility is typical of a trading and distribution company, not a franchise with pricing power. The Piotroski F-score of 7 suggests some recent fundamental improvement, and the PEG of 0.07 might tempt a growth investor, but with a near-zero current quarterly profit, that ratio is built on a fragile base. As Graham would say, a thousand speculative growth stories begin with one explosive quarter. Here there is no dividend, no clear promoter data, and an industry with no moat. At 1.91 times book, I need a margin of safety; I do not find it. The 52-week range of ₹27.16 to ₹57.00 shows how wide the swings can be. If the business can generate consistent earnings over several years, my interest would improve, but for now this is a pass. I prefer companies where returns on capital are high, earnings are repeatable, and the balance sheet is transparent. Neelkanth does not meet that test today.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer